Investments

Buyout
Held / Exited
  • biofarma logo
    Buyout

    Biofarma

    Italy

    Healthcare & life science
    Healthcare & life science

    Biofarma Group is the leader in Italy and Europe in the development, manufacturing, and packaging of food supplements, medical devices, probiotic-based products, and cosmetics. The Group is the result of a path of aggregation of 6 complementary nutraceuticals companies (Nutrilinea, Pharcoterm, Apharm, Claire, Biofarma, and the ‘Health Science’ division of Giellepi). As of today, the Group has revenue in excess of €230m and more than 800 employees.
    Biofarma offers its clients an integrated offer, from research and development, to manufacturing and packaging of finished dosage form products, including regulatory support. The Group is recognized as the innovative leader in its market, offering its customers a broad portfolio of technologies and proprietary formulations by anticipating market trends.
    The company has 4 manufacturing facilities in Mereto di Tomba (UD) (Headquarter), Gallarate (VA), San Pietro Viminario (PD), and Cusano Milanino (MI), and has 3 research and development centers which employ more than 50 R&D specialists.

We appreciate Ardian’s unique support on our growth path that helped us very much to become market leader and position us ideally for future growth.”

Daniel Schustermann Managing Director of Schustermann & Borenstein

It is an efficient team, determined and confident in its choices, and always attentive to its partners. The relationships of trust that the Ardian team builds over time, with the management teams and, beyond that, with the advisors around them, are part of their DNA.

David Aknin Lawyer